HSP90AA1 and triple-negative breast carcinoma: It has been reported that triple-negative breast cancer (TNBC) is sensitive to the Hsp90 inhibitor PU-H71 through the inhibition of the RAS/RAF/MAPK pathway and the induction of apoptosis via the degradation of AKT and BCL-XL [101].